Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa.

Rahel ThomiD YerlyN YawalkarDagmar SimonC SchlapbachR E Hunger

Published in: The British journal of dermatology (2017)

Our findings suggest that IL-32 is overexpressed in HS. Targeting IL-32 may therefore represent a new therapeutic option for the treatment of this recalcitrant disease.

Keyphrases

hidradenitis suppurativa
cancer therapy
drug delivery
replacement therapy